In November, CMS announced one of the largest Medicare Part B price hikes in the program’s history: a 14 percent premium increase. The rule increased premiums to $170.10 and standard deductibles up to $30.
The department partially attributed the hike as bracing for the potential coverage of Aduhelm, which cost at the time an average of $56,000 per person per year. Since then, Biogen announced that effective Jan. 1, it would cut the price of Aduhelm in half.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
